Bora Pharmaceuticals Appoints J.D. Mowery As Division President To Drive Growth and Innovation In the Global Cdmo Sector

Oct 15, 2024•about 1 year ago

Position

President

Company

Bora Pharmaceuticals Ltd

J.D. Mowery

TaipeiPharmaceuticalBiotechnologyManufacturing

Description

Bora Pharmaceuticals strengthens its U.S. presence with the acquisition of Emergent BioSolutions’ Baltimore-Camden facility, appointing J.D. Mowery as Division President to drive growth and innovation in the global CDMO sector.

Company Information

Company

Bora Pharmaceuticals Ltd

Location

Taipei, Taipei City, Taiwan

About

Bora Pharmaceuticals Co., Ltd. is a multinational pharmaceutical company that focuses on expanding its rare disease portfolio through strategic acquisitions. It is listed on the TWSE with a strong emphasis on innovative research and development.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Bora Pharmaceuticals Appoints J.D. Mowery As Division President To Drive Growth and Innovation In the Global Cdmo Sector

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information